Reuters logo
BRIEF-Stemline Therapeutics reports Q3 loss per share $0.68
2017年11月9日 / 晚上9点33分 / 11 天前

BRIEF-Stemline Therapeutics reports Q3 loss per share $0.68

Nov 9 (Reuters) - Stemline Therapeutics Inc

* Stemline Therapeutics reports third quarter 2017 financial results

* Q3 loss per share $0.68

* Q3 earnings per share view $-0.59 -- Thomson Reuters I/B/E/S

* Stemline Therapeutics-‍stemline ended Q3 of 2017 with $79.9 million in cash, cash equivalents and investments, as compared to $93.2 million as of June 30, 2017​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below